- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05802784
Hysteroscopic Septoplasty by Different Modalities
Hysteroscopic Septoplasty by Different Modalities: A Randomized Clinical Trial
The goal of this clinical trial is to compare in participant population ( women with uterine septum meeting the inclusion criteria) hysteroscopic septoplasty by resectoscope compared to hysteroscopic septoplasty with scissors.
The main questions to answer are:
Is there a difference in operative time ? Is there a difference in fluid used and fluid deficit? Is there a difference in complications? Is there a difference in reproductive outcome? Researchers will compare the 2 different techniques to see if there is any difference in operative outcome ( operative time, fluid used and deficit, need for second intervention, and operative and postoperative complications) and reproductive outcome.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study design:
Prospective randomized clinical trial
Study duration and location:
For at least 24 months, Patients admitted to Obstetrics and Gynecology department at Mansoura University Hospital.
Study method
At baseline, the following will be done:
- History taking: personal history, menstrual history, obstetrical and gynecological history, present and past history.
- Patient presentation (subfertility or pregnancy loss)
- Physical examination: General, abdominal and local examination.
- Diagnosis of uterine septum either by hysterosalpingogram (HSG), Three dimensional transvaginal ultrasound or office hysteroscopy.
Thereafter:
Patients will be prospectively recruited and randomized by computer program to 2 groups
Group A:
Patients in this group will undergo resection of the septum with hysteroscope and scissors. Saline will be used as a distending medium in the scissors group. Septal incision will be carried out using a thinning technique by which incisions will be made along each side of the septum alternately from one cornual end to the other
Group B:
Patients in this group will undergo resection of the septum with monopolar resectoscope , dilation of cervical os with Hegar's dilators , incision of the septum using a resectoscope with the Collins knife, monopolar energy (cut 50-70 Watt) and glycine 1.5% as the distension medium Sample size calculation Sample size was calculated using Power Analysis and Sample Size software program (PASS) version 15.0.5 for windows (2017) using the results published before with the operative duration of hysteroscopic incision in septate uterus by scissors compared to resectoscope as the primary outcome. The study reported the median operative duration as 10 minutes for resectoscope while that for scissors was 30 minutes. The null hypothesis was considered as the absence of difference between both groups regarding the operative duration. A sample size of 16 patients in each group is needed to achieve 95% power (1-β or the probability of rejecting the null hypothesis when it is false) in the proposed study using a two-sided Fisher exact test with a significance level (α or the probability of rejecting the null hypothesis when it is true) of 5% and hypothesized common standard deviation 15 in both groups. 4 patients drop-out is expected, so a total of 20 patients will be enrolled to each group
Statistical analysis Data will be analyzed using the Statistical Package of Social Science (SPSS) program for Windows (Standard version 24). The normality of data will be first tested with one-sample Kolmogorov-Smirnov test.
Qualitative data will be described using number and percent. Continuous variables will be presented as mean ± standard deviation for normally distributed data and median (IQR) for non-normal data. The following tests will be used; Chi square test: Compare qualitative variables. Fisher exact test and monte carlo test: Compare qualitative variables when expected count less than 5.
Independent t- test: Compare two quantitative variables (parametric). Mann Whitney test: Compare two quantitative variables (Non parametric). For all above mentioned statistical tests , the threshold of significance is fixed at 5% level.The results was considered significant when p ≤ 0.05. The smaller the p-value obtained, the more significant are the results.
Ethical consideration:
- Study protocol was submitted for approval by Institutional Review Board
- Approval of the managers of the health care facilities in which the study was conducted.
- Informed written consent will be obtained from each participant sharing in the study.
- Confidentiality and personal privacy will be respected in all levels of the study.
- Collected data will not be used for any other purpose.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Dakahlia
-
Mansoura, Dakahlia, Egypt, 35511
- Faculty of medicine, Mansoura University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women of reproductive age
- Seeking conception
- Diagnosis of a septate or subseptate uterus
A history of one of the following:
- Recurrent pregnancy loss
- Subfertility
- Preterm Birth
Exclusion Criteria:
- Not seeking conception
Diagnosis of septate or subseptate uterus with no history of any of the following:
- Recurrent pregnancy loss
- Subfertility
- Preterm Birth
- Contraindications for surgery
- Those who refused to participate.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Scissors arm
Patients in this group had undergone resection of the septum with hysteroscope and scissors, The scissors used was pointed, single action and semi rigid .
Saline was used as the distending medium in the scissors group.
Septal incision was carried out using shortening technique by incising the septum at the leading edge and continue dividing by moving from side to side (in narrow septum), or by thinning technique by which incisions will be made along each side of the septum alternately from one cornual end to the other (in broad septum).
The operation was stopped if the fluid deficit exceeded 2500 ml of saline.
|
In hysteroscopic septoplasty with scissors arm, incision of the septum was done by continuous flow hysteroscopy and scissors using saline as distension media.
|
|
Active Comparator: Resectoscope arm
Patients in this group had undergone resection of the septum with Monopolar 26 French resectoscope Dilation of cervical os with Hegar's dilator (up to hegar 8 or 9) , incision of the septum using a resectoscope with the Collins knife, monopolar energy (cut 40-70 Watt) and glycine 1.5% as the distension medium, using shortening or thinning incision.
The operation was stopped if the fluid deficit exceeded 1000 ml of glycine.
The delivery of distension media was conducted by automated pressure delivery system.
All patients were prescribed cyclic estrogen and progesterone for two months.
|
In hysteroscopic septoplasty with resectoscope arm, incision of the septum was done by 26 Fr monopolar resectoscope with collin's knife using glycine1.5% as distension media.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Operative time
Time Frame: During surgery
|
During surgery
|
|
Fluid deficit
Time Frame: During surgery
|
During surgery
|
|
Operative and post operative complications
Time Frame: 3 months follow up after intervention
|
3 months follow up after intervention
|
|
Need for second intervention
Time Frame: 3 months follow up after intervention
|
3 months follow up after intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pregnancy rate
Time Frame: At least 6 months follow up after intervention
|
At least 6 months follow up after intervention
|
|
Live birth rate
Time Frame: Follow up until the end of first clinical pregnancy or 6 months after surgery
|
Follow up until the end of first clinical pregnancy or 6 months after surgery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MD.20.05.324
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Recurrent Pregnancy Loss
-
University Hospital, ToulouseCompleted
-
Caroline Nørgaard-PedersenAalborg University Hospital; Department of Clinical Immunology, Odense University...CompletedRecurrent Pregnancy Loss, Not PregnantDenmark
-
Wake Forest University Health SciencesWithdrawnRecurrent Pregnancy Loss Without Current Pregnancy
-
Bagcilar Training and Research HospitalCompletedRecurrent Pregnancy Loss Without Current PregnancyTurkey
-
Shenyang Medical CollegeCentral Hospital Affiliated to Shenyang Medical Collage; The Second Hospital...CompletedAnxiety Disorder | Recurrent Pregnancy Loss Without Current PregnancyChina
-
Hospital de Clinicas de Porto AlegreUNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL (UFRGS)RecruitingRecurrent Pregnancy Loss(RPL)Brazil
-
Nora Therapeutics, Inc.UnknownRecurrent Miscarriage | Recurrent Pregnancy LossUnited Kingdom
-
Mỹ Đức HospitalRecruitingVaginal Microbiome | Recurrent Pregnancy Loss, Not PregnantVietnam
-
Shenyang Medical CollegeCentral Hospital Affiliated to Shenyang Medical CollageRecruitingAnxiety | Recurrent Pregnancy LossChina
-
Soroka University Medical CenterUnknownRecurrent Miscarriage | Recurrent Pregnancy Loss(RPL)Israel
Clinical Trials on Hysteroscopic septoplasty with scissors
-
Northwestern UniversityRecruitingTreatment Side Effects | Treatment | Surgical Complication | Uterine Septum | Septum; UterusUnited States
-
University Hospital Sestre MilosrdniceEnrolling by invitationBreathing Mechanics | Breathing Disorder During Sleeping | Nasal PatencyCroatia
-
Brugmann University HospitalWithdrawnSymptomatic Submucosal MyomaBelgium, France
-
Università degli Studi dell'InsubriaCompletedPost-Menopausal Bleeding | Post-Menopausal Endometrial ThicknessItaly
-
Al-Azhar UniversityCompletedSnoring | Obstructive Sleep Apnea | Nasal SurgeryEgypt
-
Tanta UniversityRecruiting
-
Ege UniversityCompletedEpisiotomy WoundTurkey
-
Baskent UniversityCompletedto Compare Lacrimal Dilator-facilitated Incisionless and Standard STB With Wescott ScissorsTurkey
-
Cairo UniversityCompletedPostmenopausal BleedingEgypt
-
Centre Hospitalier Universitaire de la RéunionCompleted